San Carlos, Calif., April 22,2024 – Alessa Therapeutics Inc. today announced that they will be presenting a podium poster at the 2024 annual American Association of Urology (AUA) annual meeting in San Antonio, TX.
Poster Title: A Phase 1 Safety, PK and Preliminary Efficacy Study of Localized Therapy using Biolen (Bicalutamide) Implants for Early-Stage Prostate Cancer
Session Date and Time: Friday 03 May 2024, 1:00 to 3:00 PM
Building: Henry B. Gonzalez Convention Center; Room: 225D
Published Abstract Number: 24-7369
About Alessa Therapeutics
Founded in 2018 and based on technology developed at the UCSF, Alessa Therapeutics is a privately held company focused on developing selective and sustained localized drug delivery for early interception of cancer. Alessa is financed by Mission BioCapital. For more information on Alessa Therapeutics, visit www.alessatherapeutics.com or email alessa@alessatherapeutics.com.